Drugs / HA-Irinotecan
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01290783 | Dec 2011 → Oct 2014 | colorectal cancer | Alchemia Oncology | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HA-Irinotecan | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01290783 ↗ |
| Known as | Hyaluronic acid-Irinotecan | “the FOLFIRI regimen with "Hyaluronic acid-Irinotecan" or "HA-Irinotecan" regimen” NCT01290783 ↗ |
| Route | Intravenous | “HA-Irinotecan (irinotecan 180 mg/m2), IV, over 90 minutes, day 1” NCT01290783 ↗ |